Results 331 to 340 of about 7,595,633 (393)
Molecular Oncology, EarlyView.Microglia (BV2) and IL‐4‐treated BMDMs promote astrocytoma clustering and inhibit tumor growth, not shown in other macrophage cells. In vivo, microglial co‐implantation enhances CD8+ T cell infiltration, elevates Granzyme B, lowers circulating MDSCs, and extends survival only in immune‐competent mice, but not in immune‐deficient mice.
Tzu‐Chieh Sun +5 more
wiley +1 more source
El sistema inmune, herramienta estratégica en la batalla contra el cáncer
, 2000 Flavio Salazar O.
openalex +1 more source
Associations between social drivers of health and breast cancer stage at diagnosis among U.S. Black women. [PDF]
NPJ Breast CancerBarnard ME +13 more
europepmc +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Molecular Oncology, EarlyView.Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
Análisis de un programa de detección precoz de cáncer de mama en una zona rural
, 2000 Alfonso Escribano-Hernández +2 more
openalex +1 more source
The natural history of prostate cancer. [PDF]
Can Urol Assoc JO'Connell C, Bernardino RM, Fleshner NE.
europepmc +1 more source
Molecular Oncology, EarlyView.Loss‐of‐function mutations in the scaffold subunit of protein phosphatase 2A (PP2A), PPP2R1A, sensitize ovarian clear cell carcinoma to immune checkpoint blockade (ICB) by enhancing the interferon gamma response and promoting antitumor immune cell infiltration.
Matheus Henrique Dias, René Bernards
wiley +1 more source